Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat

Overview of attention for article published in Thorax, May 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 5 X users

patent: 3 patents

Citations

dimensions_citation: 170 Dimensions

Readers on

mendeley: 135 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

MESENCHYMAL STEM CELLS FROM WHARTON'S JELLY FOR TREATING SEPSIS

Application EP-4091618-A1

European Patent Office

MESENCHYMAL STEM CELLS OBTAINED FROM WHARTON'S JELLY FOR THE TREATMENT OF SEPSIS

Application WO-2018158542-A1

World Intellectual Property Organisation (WIPO)

AEROSOLIZATION OF STEM CELLS OR STEM CELL DERIVATIVES FOR PULMONARY DELIVERY

Application WO-2017132609-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.